Related references
Note: Only part of the references are listed.Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities
Arwa Z. Al-Riyami et al.
VOX SANGUINIS (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 and Blood Safety: Help with a Dilemma
Roger Y. Dodd et al.
TRANSFUSION MEDICINE REVIEWS (2020)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
Patrizia Accorsi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
COVID-19 Convalescent Plasma: Now Is the Time for Better Science
Sunny Dzik
TRANSFUSION MEDICINE REVIEWS (2020)
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
H. Cliff Sullivan et al.
TRANSFUSION MEDICINE REVIEWS (2020)
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial .
Cesare Perotti et al.
HAEMATOLOGICA (2020)
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo et al.
IMMUNITY (2020)
Effects of the COVID-19 pandemic on supply and use of blood for transfusion
Simon J. Stanworth et al.
LANCET HAEMATOLOGY (2020)
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pooling Data From Individual Clinical Trials in the COVID-19 Era
Eva Petkova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Response to COVID-19 in persons with haematological cancers
Stefan Hatzl et al.
LEUKEMIA (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
Pierre Cappy et al.
BLOOD (2020)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso et al.
BLOOD (2020)
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
Lars F. Westblade et al.
CANCER CELL (2020)
Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic
Sarah Vossoughi et al.
TRANSFUSION (2020)
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Hassan Abolghasemi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
Olivier Garraud
TRANSFUSION AND APHERESIS SCIENCE (2020)
Treatment for emerging viruses: Convalescent plasma and COVID-19
Bethany L. Brown et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020
Roger Y. Dodd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 clinical trials: learning from exceptions in the research chaos
Kari A. O. Tikkinen et al.
NATURE MEDICINE (2020)
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome
Caroline Diorio et al.
PEDIATRIC BLOOD & CANCER (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Blood use and transfusion needs at a large health care system in Washington state during theSARS-CoV-2 pandemic
Monica B. Pagano et al.
TRANSFUSION (2020)
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19
Thomas Lung et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Convalescent plasma for covid-19
Lise J. Estcourt et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Convalescent plasma is ineffective for covid-19 Lessons from the Placid Trial
Elizabeth B. Pathak
BMJ-BRITISH MEDICAL JOURNAL (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
Olivia Swann et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Platelets mediate serological memory to neutralize viruses in vitro and in vivo
Waltraud C. Schrottmaier et al.
BLOOD ADVANCES (2020)
First do no harm-beware the risk oftherapeutic plasma exchangein severe COVID-19
Klaus Stahl et al.
CRITICAL CARE (2020)
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
Theodora Psaltopoulou et al.
HEMASPHERE (2020)
Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers
Hannah Knaup et al.
CRITICAL CARE (2018)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Share Paper
